Drug research and development - Beijing SH biotechnology Co., Ltd.,

Drug research and development Cell therapy Cell storage CRO Services Cooperative Agency

HOMEProducts and ServicesDrug research and development

MSCs modified with HGF for the treatment of arteriosclerosis occlusion of lower limbs

HGF-modified MSCs can enhance angiogenesis, and can effectively alleviate the rest pain of patients in the early clinical studies of limb ischemia

Preclinical study of MSCs modified with HGF in the treatment of lung injury（ chronic obstructive pulmonary disease / pulmonary fibrosis / paraquat）

Gene modified enhanced MSCs, as a second-generation product, has the dual advantages of cell therapy and gene the

Dental pulp mesenchymal stem cell injection for the treatment of psoriasis

Psoriasis is an immune disease The existing treatments of Psoriasis can only relieve symptoms to a certain exten

Dental pulp mesenchymal stem cell injection for the treatment of periodontitisDental pulp mesenchymal stem cell injection for the treatment of periodontitis

The stem cell research team cooperated with the Institute of Oral Transformational Medicine of Capital Medical Uni

Recombinant Protein Drugs: Recombinant neohirudin for injection

The company and the Institute of Radiation and Radiation Medicine of the Academy of Military Medical Sciences jointly developed a new anticoagulant drug - recombinant neohirudin for injection (EH)

About Us

Products and Services

News Information

Join Us

Contact Us

Follow WeChat

Follow Micro-Blog

Copyright © 2014 All Rights Reserved.　 Beijing SH biotechnology Co., Ltd.,